Abstract:Objective To determine the level of serum chemerin and investigate the correlation between chemerin and ventricular remodeling in patients with chronic heart failure (CHF). Methods Sixty patients with chronic heart failure were selected as CHF group in this study (16 cases with cardiac function grade II, 26 cases with grade III, and 18 cases with grade IV). Menwhile 60 patients with normal cardiac function were enrolled as control group. Ultrasound echocardiography was performed to measure left ventricular ejection fraction (LVEF), left atrial diameter (LAD), left ventricular end diastolic diameter (LVEDD), interventricular septal thickness (IVST) and left ventricular posterior wall thickness (LVPWT), and then left ventricular mass (LVM) and left ventricular mass index (LVMI) were calculated. The serum level of chemerin was measured in all the selected subjects. Results The serum level of chemerin in the patients of the CHF group was significantly higher than that in the control group and increased with the exacerbation of heart failure (P < 0.05). And the serum chemerin level was positively correlated with LVMI (r = 0.401, P = 0.022), but was negatively correlated with LVEF (r = -0.455, P = 0.021). Conclusions Serum chemerin is related to the left ventricular remodeling and can be identified as a new marker for heart failure. It may be used to assess the extent of heart failure and evaluate the prognosis of heart failure.